Insulin Glargine and Lixisenatide
1 NDC across 1 manufacturer|0 Generic,1 Brand
▸ More about this market▾ Less
Insulin Glargine and Lixisenatide is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $57.06 to $57.06 per ML. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$57.06 – $57.06
per ML
7d Activity
avg -0.1% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Sanofi-Aventis U.S. LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
GLP-1 Receptor Agonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing INSULIN GLARGINE AND LIXISENATIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SOLIQUA 100 UNIT-33 MCG/ML PEN | $57.0615 per ML | -0.05% |
Frequently Asked Questions
How many Insulin Glargine and Lixisenatide products are on the market?
The Insulin Glargine and Lixisenatide drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Insulin Glargine and Lixisenatide?
NADAC reference prices for Insulin Glargine and Lixisenatide range from $57.0615 to $57.0615 per ML.
Which manufacturers make Insulin Glargine and Lixisenatide?
1 manufacturer lists Insulin Glargine and Lixisenatide in NADAC. Ranked by number of NDCs, the largest are Sanofi-Aventis U.S. LLC (1).
How has the price of Insulin Glargine and Lixisenatide changed recently?
Over the past 7 days, 0 Insulin Glargine and Lixisenatide NDCs rose and 2 fell, with a market-wide average change of -0.1%.